Peer-reviewed veterinary case report
Endoscopic laser treatment to ease nasal cancer symptoms in dogs
By Bottero, Enrico et al.·Published in The Canadian veterinary journal = La revue veterinaire canadienne·2025·Department of Interventional Pulmonology and Ear-Nose-Throat Medicine and Surgery, Italy·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Palliative endoscopic debulking treatment of canine nasal carcinoma - 35 cases (2016 to 2019): A retrospective multicentric study.
- Species:
- dog
Plain-English summary
A group of 35 dogs with nasal cancer underwent a special laser treatment called endoscopic diode laser and forceps debulking (EDLFD) to help manage their symptoms. Many of these dogs had been suffering from issues like nasal discharge, sneezing, and facial deformities for over three months and had not found relief from other treatments. After the EDLFD procedure, more than half of the dogs showed significant improvement in their quality of life within three months, and there were no major complications from the surgery. On average, the dogs lived about 11 months after the treatment, indicating that EDLFD can be a helpful option for dogs with nasal cancer.
People also search for: dog nasal cancer treatment · endoscopic laser treatment for dogs · nasal discharge in dogs · palliative care for dog cancer
Abstract
OBJECTIVE: This retrospective study investigated the palliative efficacy of endoscopic diode laser and forceps debulking (EDLFD) for managing nasal carcinoma in dogs. ANIMALS AND PROCEDURE: Thirty-five dogs with histopathological diagnosis of nasal carcinoma that underwent EDLFD treatment were included. Descriptive statistics were reported regarding age, sex, neutering status, weight, body condition score, epistaxis, sneezing, stertor, reverse sneezing, nasal discharge, facial deformity, tumor laterality, modified Adams staging, quality of life at presentation, histotypes, EDLFD duration, adjuvant metronomic chemotherapy, and survival time. RESULTS: Eighteen (51%) dogs exhibited clinical signs persisting for > 3 mo, with 80% failing to respond to previous medical treatments. Unilateral discharge was the most common complaint. Tumor location was categorized as nasal in 43% of cases (unilateral: 37% and bilateral: 6%) and as nasal and nasopharyngeal in 57%. No major intraoperative or postoperative complications were observed associated with EDLFD. The median survival time was 336 d. A clinical benefit > 50% was observed 3 mo after EDLFD. CONCLUSION AND CLINICAL RELEVANCE: We concluded that EDLFD was a viable palliative approach for nasal carcinoma in dogs, offering promising results in improving quality of life.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/39898163/